These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1254364)

  • 1. Contingent naloxone treatment of the narcotic addict: a pilot study.
    Kurland AA; McCabe L; Hanlon T
    Int J Addict; 1976; 11(1):131-42. PubMed ID: 1254364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingent naloxone (N-allylnoroxymorphone) treatment of the paroled narcotic addict.
    Kurland AA; McCabe L; Hanlon TE
    Int Pharmacopsychiatry; 1975; 10(3):157-68. PubMed ID: 1099047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcotic antagonist treatment of addict parolees--the failure of an effective approach.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Compr Psychiatry; 1977; 18(3):211-9. PubMed ID: 858238
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report.
    Kurland AA; McCabe L
    J Clin Pharmacol; 1976 Jan; 16(1):66-74. PubMed ID: 1107361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone maintenance and narcotic blocking drugs. Appendix.
    Wikler A
    Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and value of naloxone as a therapeutic aid.
    Wiesen RL; Rich CR; Wang RI; Stockdale SL
    Drug Alcohol Depend; 1977 Mar; 2(2):123-30. PubMed ID: 858271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study.
    Lindstrom HA; Clemency BM; Snyder R; Consiglio JD; May PR; Moscati RM
    Prehosp Disaster Med; 2015 Aug; 30(4):385-9. PubMed ID: 26061280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and modification of opiate reinforcement.
    Meyer RE; McNamee HB; Mirin SM; Altman JL
    Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What heroin users tell us about overdose.
    Baca CT; Grant KJ
    J Addict Dis; 2007; 26(4):63-8. PubMed ID: 18032233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 14. Offer of a quick fix.
    Gould M
    Nurs Stand; 2011 Nov 16-22; 26(11):24-5. PubMed ID: 22204109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioral paradigm for the evaluation of narcotic antagonists.
    Meyer RE; Mirin SM; Altman JL; McNamee HB
    Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone and the narcotic abuser: a controlled study of partial blockade.
    Kurland AA; Hanlon TE; McCabe OL
    Int J Addict; 1974; 9(5):663-72. PubMed ID: 4155406
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
    Comer SD; Collins ED
    J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
    Comer SD; Walker EA; Collins ED
    Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A possibility of the use of low naloxone dosages in the treatment of heroin dependence].
    Nadezhdin AV; Litvinova SV; Tetenova EIu; Mikhalev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):56-7. PubMed ID: 16457136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.